Cargando…
Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis
BACKGROUND: The discovery of molecular markers associated with various breast cancer subtypes has greatly improved the treatment and outcome of breast cancer patients. Unfortunately, breast cancer cells acquire resistance to various therapies. Mounting evidence suggests that resistance is rooted in...
Autores principales: | Hagen, Katie R, Zeng, Xiangbin, Lee, Mi-Young, Tucker Kahn, Shannon, Harrison Pitner, Mary Kathryn, Zaky, Sandra S, Liu, Yuan, O’Regan, Ruth M, Deng, Xingming, Saavedra, Harold I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733890/ https://www.ncbi.nlm.nih.gov/pubmed/23886499 http://dx.doi.org/10.1186/1747-1028-8-10 |
Ejemplares similares
-
Cdk4 and Nek2 Signal Binucleation and Centrosome Amplification in a Her2+ Breast Cancer Model
por: Harrison Pitner, Mary Kathryn, et al.
Publicado: (2013) -
CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
por: Yang, Yilan, et al.
Publicado: (2020) -
Silencing of R-Spondin1 increases radiosensitivity of glioma cells
por: Gu, Xuefeng, et al.
Publicado: (2015) -
CDK4/6 Inhibitor Palbociclib Amplifies the Radiosensitivity to Nasopharyngeal Carcinoma Cells via Mediating Apoptosis and Suppressing DNA Damage Repair
por: Xie, Xianhe, et al.
Publicado: (2019) -
Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin
por: Rowe, Danica L., et al.
Publicado: (2009)